Andrew Freedman Quoted in Benzinga on Chinese Company Take-Private Offers

Firm News

Olshan Activist Partner Andrew Freedman was quoted by Benzinga in an article discussing Chinese company go-private dealings, detailing how executive management teams are seeking to take their companies private at the expense of their shareholders. The editorial examines take-private deals by WuXi, Renren, Jiayuan.com International Ltd., China Nepstar Chain Drugstore Ltd. and other U.S.-listed Chinese companies. Freedman notes that this trend leaves investors stuck with a double-edged sword, as there is little legal recourse in China and notably the Caymans to challenge the unfair deals due to lack of corporate governance options.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager
mmehaj@olshanlaw.com
212.451.2319


Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.